Product Information
SUMATRIPTAN 6 MG/0.5 ML VIAL is a generic product labeled by Somerset Therapeutics, LLC, priced at $14.5436 per ML under NDC 70069080405. Its NADAC has been published 150 times since Jan 5, 2022.
FDA first approved this application on Jul 13, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
6 mg/.5mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069080405
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
10/23/2024
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA213998FDA Approved
7/13/2021
TE Code
AP
On Market Since
10/25/2021
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has been published 150 times since Jan 5, 2022, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.5436 per ML |
|---|---|
| All-time high | $21.7540 (May 11, 2022) |
| All-time low | $12.4674 (May 22, 2024) |
| Median price | $17.2069 |
| Average price | $17.1058 |
| Largest weekly change | +31.8% (Feb 22, 2023) |
| Weeks tracked | 150 |
| Tracking since | Jan 5, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-6.5%
5Y
N/A
All
-20.0%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sumatriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML VIAL, manufactured by Somerset Therapeutics, LLC, is $14.5436 per ML (NDC 70069080405), effective Nov 13, 2024.
How has the price of SUMATRIPTAN 6 MG/0.5 ML VIAL changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has declined 20.0%. It has been tracked across 150 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML VIAL?
Since Jan 5, 2022, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has ranged from a low of $12.4674 (May 22, 2024) to a high of $21.7540 (May 11, 2022), with a median of $17.2069 per ML.
Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN 6 MG/0.5 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures SUMATRIPTAN 6 MG/0.5 ML VIAL?
SUMATRIPTAN 6 MG/0.5 ML VIAL (NDC 70069080405) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.